CDKN2A and non-small cell lung carcinoma: The mechanism of P16 gene inactivation was often caused by deletion, methylation, or gene mutation causing an alteration of protein production (Lo et al., 1996), similar to those found in NPC and non-small cell lung carcinoma (NSCLC) (Gulley et al., 1998; Tam et al., 2013).